Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Osteopore Ltd. ( (AU:OSX) ) has issued an update.
Osteopore Limited has reported a record quarterly revenue of AUD 835K for Q2 CY25, marking a 15% increase quarter-on-quarter and an 11% rise year-on-year. The company has also secured EU MDR clearance for its custom orthopaedic and cranial implants, which is expected to open new revenue streams and enhance its market presence in the European Union.
More about Osteopore Ltd.
Osteopore Limited is a manufacturer of regenerative implants that facilitate natural tissue regeneration. The company focuses on producing custom and off-the-shelf orthopaedic and cranial implants, primarily targeting the European market.
Average Trading Volume: 2,491,755
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.49M
See more data about OSX stock on TipRanks’ Stock Analysis page.